1 |
Yasuda SU, Zhang L, Huang SM, The role of ethnicity in Variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther 2008; 84(3): 417-423.
DOI
|
2 |
McDowell SE, Coleman. JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006; 332(7551): 1177-82.
DOI
|
3 |
Larisa H, Lam F. Pharmacogenetics. In: Dipitro JT, et al., eds Pharmacotherapy: a pathophysiologic approach. 5th ed. New York: Mc Graw Hill, 2002; 55-59.
|
4 |
Miners JO, Birkett DJ. Cytochrome P450 2C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998; 45(6): 525-38.
DOI
|
5 |
Scott SA, Khasawneh R, Peter I, et al., Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups. Pharmacogenomics 2010; 11(6): 781-91.
DOI
|
6 |
McDowell SE, Coleman. JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006; 332(7551): 1177-82.
DOI
|
7 |
가교자료평가 가이드라인. 식품의약품안전청. 발간등록번호 11-1470000-001719-01
|
8 |
Campbell D, Chui M, Pharmerging Shake-up: new imperatives in a re-defined world. Northwalk: IMS, 2010.
|
9 |
PDR(R) Electronic Library on CD-ROM, 64 edition. Montvale, NJ: PDR Network, LLC, 2010.
|
10 |
ICH, Ethnic Factors In The Acceptability of Foreign Clinical Data E5(R1), Feb. 1998.(http://www.ich.org/fileadmin/Public_ Web_Site/ICH_Products/Guidelines/Efficacy/E5_R1/Step4/ E5_R1__Guideline.pdf)
|
11 |
FDA. Investigational new drug applications and new drug applications Final rule. Fed Regist 1998; 63(28): 6854-62.
|
12 |
FDA. Guidance for industry Collection of Race and Ethnicity Data in Clinical Trials, Sep. 2005. (http://www. fda.gov/downloads/RegulatoryInformation/Guidances/ucm 126396.pdf)
|
13 |
Department of Health and Human Service (http:// www.hhs.gov)
|
14 |
Centers for Disease Control and Prevention (http:// www.cdc.gov)
|
15 |
Prostate Cancer Screening: A Decision Guide for African Americans, CDC, 2003
|
16 |
Rotimi CN, Jorde LB. Ancestry and disease in the age of genomic medicine. N Engl J Med. 2010; 363(16): 1551-8.
DOI
|
17 |
Asian & Pacic Islander American Health Forum (http:// www.apiahf.org)
|
18 |
The International Society on Hypertension in Blacks (http://www.ishib.org)
|
19 |
Dugluas JG, Bakris GL, Epstein M, et al., Management of high blood pressure in african americans. Arch Intern Med 2003; 163(5): 525-41.
DOI
|
20 |
Flack JM, Sica DA, Bakris G, et al., Management of high blood pressure in blacks; an update of the international society on hypertension in blacks consensus statement. Hypertension 2010; 56: 780-800.
DOI
|
21 |
Séguin B, Hardy B, Singer PA, et al., : recontextualizing the race debate. Pharmacogenomics J 2008; 8(3): 169-73.
DOI
|